Saccadometry in Primary Headache Syndromes
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Migraine is one of the commonest neurological disorders, affecting up to 12% of the general population, but remains relatively under-diagnosed and under-treated. Migraine has a wide socioeconomic impact and brings a large economic burden; estimates suggest that disability due to migraine costs > €27 billion per annum across Europe. Despite its prevalence and impact, migraine pathophysiology is poorly understood. A wider understanding of the functional changes in this disorder would be beneficial to both diagnosis and treatment.
Saccades are the rapid eye movements we make when moving the eyes to a new object in our visual field. Reaction time studies have been used to investigate Huntington's disease and Parkinson's disease with great success. These use saccadic tasks (monitoring eye movements). Even at rest we make approximately three saccades per second, so a lot of data can quickly be gathered with non-invasive testing. We hope to understand more of the underlying mechanisms of migraine by studying reaction time in migraine patients.
Our previous pilot study, with less stringent inclusion and exclusion criteria, looked at fewer patients (32 migraineurs and 32 controls), and found that migraineurs showed significantly different saccadic patterns to non-migraineurs.
This study firstly seeks to corroborate the saccadometric findings of our earlier pilot study in a group of migraineurs, and secondly to explore the specificity of these findings in migraine by also studying patients with another primary headache syndrome, namely cluster headache.
Migraine is known to be a dynamic disorder, with previous studies showing longitudinal changes in the migraine brain. To explore this further we hope to record longitudinally (Every day for 21 days) in a small subset of migraineurs to identify potential longitudinal changes in saccadic reaction time. Because of the portability of the equipment this could be done in the subjects own home if they preferred.
| Condition |
|---|
|
Migraine Cluster Headache Control Menstrual Migraine |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Saccadometry in Primary Headache Syndromes |
| Estimated Enrollment: | 162 |
| Study Start Date: | August 2011 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Episodic Migraine. |
| menstrual migraine |
| Cluster Headache patients |
| control (non-headache group) |
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
From hospital Headache clinics (secondary and tertiary)
Inclusion Criteria:
- Male or female and aged between 18 and 60 years in good general health apart from suffering from headaches (test group).
- Migraine and cluster headache will be diagnosed according to ICHD-II diagnostic criteria (6).
Migraineurs must suffer at least two migraine attacks per year and no more than 5 attacks per month.
-
Exclusion Criteria:
- Any other neurological disorder such as stroke, multiple sclerosis, epilepsy, concussion within the past year, psychiatric disorders, visual disorders.
- Use of migraine prophylactic medication in the last month or acute migraine therapy in the 3 days prior to testing.
- Patients on any medication to treat depression in their case
Headache during testing or within 3 days before and after testing.
-
Contacts and Locations| Contact: Manjit Matharu, BSc MBChB MRCP PhD | 08451555000 Ext 723664 | m.matharu@uclmail.net |
| United Kingdom | |
| The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, and The John Radcliffe hospital, Oxford, The Whittington Hospital N19 5NF London | Not yet recruiting |
| London, United Kingdom, WC1N 3BG | |
| Contact: Tim Young, BSc MBBS MRCP PhD | |
More Information
No publications provided
| Responsible Party: | Dr Manjit Matharu, Senior Lecturer and Honorary Consultant Neurologist, The National Hospital for Neurology & Neurosurgery, University College London Hospital |
| ClinicalTrials.gov Identifier: | NCT01395264 History of Changes |
| Other Study ID Numbers: | 10/0366 |
| Study First Received: | July 14, 2011 |
| Last Updated: | July 14, 2011 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Additional relevant MeSH terms:
|
Headache Disorders Headache Disorders, Primary Cluster Headache Headache Migraine Disorders Premenstrual Syndrome Trigeminal Autonomic Cephalalgias Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Menstruation Disturbances Pathologic Processes |
ClinicalTrials.gov processed this record on May 23, 2013